Hudson Bay Capital Management LP - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$1,923,000
-53.2%
17,000
-58.5%
0.04%
-29.1%
Q1 2017$4,105,000
-33.5%
41,000
-28.6%
0.06%
-14.1%
Q4 2016$6,172,00057,4000.06%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2017
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders